Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 6, 2014 - Issue
Submit an article Journal homepage
119
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

Daniel T Grima1 Cornerstone Research Group, Burlington, ON, CanadaCorrespondence[email protected]
,
Stephen T Brown1 Cornerstone Research Group, Burlington, ON, Canada
,
Laveena Kamboj2 AstraZeneca Canada, Mississauga, ON, Canada
,
Kevin R Bainey3 Mazankowski Alberta Heart Institute/University of Alberta Hospital, Edmonton, AB, Canada
,
Ron Goeree4 Program for Assessment of Technology in Health, St Joseph’s Hospital, Hamilton, ON, Canada;5 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
,
Paul Oh6 University Health Network, Toronto, ON, Canada
,
Krishnan Ramanathan7 St Paul’s Hospital, Vancouver, BC
&
Shaun G Goodman8 St Michael’s Hospital, University of Toronto, Toronto, ON, Canada
 show all
Pages 49-62 | Published online: 24 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mark Nuijten, Livia Dainelli, Bahareh Rasouli, Krysmaru Araujo Torres, Moreno Perugini & Agnieszka Marczewska. (2021) A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer’s Perspective. Diabetes, Metabolic Syndrome and Obesity 14, pages 3147-3160.
Read now

Articles from other publishers (11)

Jarir At Thobari, Lucia Krisdinarti, Dhite Nugroho, Jonathan Haposan, Isman Firdaus, Rr. Arum Ramadhyan Suryandani, Muhammad Munawar & Jimmy Agung. (2022) Cost-Effectiveness of Ticagrelor for Acute Coronary Disease to Prevent Cardiovascular Events in Three Hospitals in Indonesia. Open Access Macedonian Journal of Medical Sciences 10:A, pages 1211-1217.
Crossref
Thuy Thi Thu Nguyen, Dung Van Do, Carl Mellstrom, Tuan Quang Nguyen, Hung Manh Pham, Sy Van Hoang, Thinh Cong Luu & Tri Le Phuong. (2021) Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers’ Perspective. Advances in Therapy 38:7, pages 4026-4039.
Crossref
Laura Pirhonen, Hanna Gyllensten, Andreas Fors & Kristian Bolin. (2020) Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. The European Journal of Health Economics 21:9, pages 1317-1327.
Crossref
Yu Fu, Xin-yi Zhang, Si-bei Qin, Xiao-yan Nie, Lu-wen Shi, Hong Shao & Jian Liu. (2020) Cost–effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome . Pharmacogenomics 21:1, pages 33-42.
Crossref
Bin Wu, Ruoyan Gai Tobe, Yuchen Liu & Ben He. (2018) Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries. Clinical Drug Investigation 38:7, pages 621-630.
Crossref
Arinze Nkemdirim OkereKyrian EzenduAbdrahmane BertheVakaramoko Diaby. (2018) An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention. Journal of Managed Care & Specialty Pharmacy 24:2, pages 142-152.
Crossref
Y Wang, B P Yan, D Liew & V W Y Lee. (2017) Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome. The Pharmacogenomics Journal 18:1, pages 113-120.
Crossref
Laveena Kamboj, Paul Oh, Mitchell Levine, Srinu Kammila, William Casey, Don Harterre & Ron Goeree. (2016) Cost effectiveness of a systematic guidelines-based approach to the prevention and management of vascular disease in a primary care setting. International Journal of Cardiology 203, pages 893-899.
Crossref
José Luis López Sendón, Magda Heras, Francisco Javier Carrera Hueso, Max Brosa & Margarita Capel. (2015) Análisis coste-efectividad del uso de ticagrelor frente a clopidogrel en el tratamiento del síndrome coronario agudo en España. PharmacoEconomics Spanish Research Articles 12:4, pages 137-146.
Crossref
Eugenia Gkaliagkousi, Eleni Gavriilaki & Stella Douma. (2015) Antiplatelet Treatment in Essential Hypertension: Where Do We Stand?. Current Hypertension Reports 17:4.
Crossref
. (2014) Ticagrelor good value for money in ACS in Canada. PharmacoEconomics & Outcomes News 696:1, pages 8-8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.